No profile data available.
Cannabis Bioscience International Holdings, Inc. (CBIH) is a healthcare company in the trial phase contract research industry, based in Houston, United States, with about 2 full-time employees.
It reported revenue of $303,022 for fiscal year 2025, up 21.8% from fiscal year 2024, and net income of -$548,820. In Q3 2026 (the quarter ended February 28, 2026) revenue was $11,205, down 25.0% from a year before. Its market capitalization was $2.33 million as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended May 31, 2025; market data as of October 8, 2026.
Cannabis Bioscience International Holdings, Inc. engages in the provision of educational systems that focuses on medical cannabis in the United States and Latin America, and internationally.
Cannabis Bioscience International reported $303,022 in revenue for fiscal year 2025, up 21.8% from $248,841 in fiscal year 2024. In Q3 2026 revenue was $11,205.
$2.33 million as of October 8, 2026.
Listed companies of a similar size in the same industry (trial phase contract research) include Iqvia Holdings Inc. (IQV), Medpace Holdings, Inc. (MEDP), Fortrea Holdings Inc. (FTRE).